The FDA Issues Hemp-CBD Warning Letters and a Consumer Update
Canna Law Blog
NOVEMBER 29, 2019
The Food and Drug Administration (“FDA”) had a busy Monday this week. On November 25, the agency issued warning letters to 15 businesses selling hemp-derived CBD (“Hemp-CBD”) products as unapproved drugs. The FDA also released updated consumer guidance on Hemp-CBD. Warning Letters.